ESALFEisai Co., Ltd.

About Eisai Co., Ltd. (ESALF)

Eisai Co., Ltd. (ESALF) is a Drug Manufacturers - Specialty & Generic company headquartered in Tokyo, Japan whose shares trade over-the-counter on the Pink tier.

Eisai Co. and its subsidiaries are engaged in the manufacture and sale of pharmaceuticals, consumer health care products, diagnostic products, chemicals and food additives, and animal health products. Co.'s products include antiallergy agent, osteoporosis treatment, gastritis/gastric ulcer medication, vitamins, food preservative, flavoring agent, and sweetening material. Co. is also engaged in the manufacture and sale of pharmaceutical production system and machines.

ESALF key facts

Ticker symbol

ESALF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Tokyo, Japan

Country of incorporation

JP

Estimated market cap

$6.51B (as of Apr 15, 2025)

Shares outstanding

286,685,000

Reporting standard

International Reporting: Tokyo Stock Exchange

Audit status

Audited

Fiscal year end

3/31

Eisai Co., Ltd. leadership

• Haruo Naito — President, CEO
• Hideaki Matsui — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with E